InterventionsHumans365 daysCohort study

Association of GLP-1-based therapy with asthma-related outcomes in patients with obesity: a propensity-matched retrospective cohort study

Expert Review of Respiratory Medicine

The paper

Cameron Dean McCraw, Dominique Rose Grayeb, Navneet Gupta,

Palwasha Zafar, Anam Javed, Kainat, Zayaan A. Adrish, Humza Saeed, Abu Baker Sheikh,

Adeel Nasrullah

University of New Mexico · Allegheny Health Network

Expert Review of Respiratory Medicine · 14 Sep 2026

doi.org/10.1080/17476348.2026.2730537 PubMed 42733229

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026